ID

36965

Description

Study ID: 102146 Clinical Study ID: SUM102146 Study Title: An open-label, randomized, three-period crossover study to demonstrate the bioequivalence of sumatriptan 4 mg STATdose to IMITREX™ 6 mg STATdose after dose-normalization, and to assess the relative bioavailability of 4 mg sumatriptan injected using the STATdose device compared to 4 mg sumatriptan injected manually Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran Study Indication: Migraine Disorders

Mots-clés

Versions (1)
  1. 24/06/2019 24/06/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

24 juin 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Bioequivalence of Sumatriptan 4 mg STATdose to IMITREX™ 6 mg STATdose; 102146

Anglais

Investigational Product Discontinuation

1 Formulaires  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject number
Description

Clinical Trial Subject Unique Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Investigational Product Discontinuation
Description

Investigational Product Discontinuation

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0805733
Was the investigational product stopped permanently before the end of the scheduled dosing period?
Description

Experimental drug, Discontinued

Type de données

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1444662
If YES, check the primary reason the investigational product was stopped, check one
Description

Experimental drug, Discontinued, Reason and justification

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0566251
Specify
Description

Experimental drug, Discontinued, Reason and justification

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0566251
Retour au début de la page

Similar models

Investigational Product Discontinuation

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Clinical Trial Subject Unique Identifier
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item Group
Investigational Product Discontinuation
C0304229 (UMLS CUI-1)
C0805733 (UMLS CUI-2)
Experimental drug, Discontinued
Item
Was the investigational product stopped permanently before the end of the scheduled dosing period?
boolean
C0304229 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
Item
If YES, check the primary reason the investigational product was stopped, check one
text
C0304229 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Experimental drug, Discontinued, Reason and justification
Code List
If YES, check the primary reason the investigational product was stopped, check one
CL Item
Adverse event  (1)
CL Item
Consent withdrawn  (2)
CL Item
Lost to follow up  (3)
CL Item
Protocol violation  (4)
CL Item
Other (5)
Experimental drug, Discontinued, Reason and justification
Item
Specify
text
C0304229 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial